Allstate Corporation’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.1M Buy
+41,326
New +$1.93M 0.02% 498
2025
Q2
Sell
-14,448
Closed -$410K 426
2025
Q1
$410K Buy
14,448
+4,934
+52% +$175K 0.01% 534
2024
Q4
$396K Buy
+9,514
New +$455K 0.01% 540
2023
Q1
Sell
-14,190
Closed -$2.55M 437
2022
Q4
$2.55M Buy
14,190
+179
+1% +$29.3K 0.08% 170
2022
Q3
$1.66M Buy
14,011
+335
+2% +$50.8K 0.05% 220
2022
Q2
$1.95M Sell
13,676
-4,642
-25% -$664K 0.06% 189
2022
Q1
$3.15M Sell
18,318
-8,422
-31% -$1.42M 0.08% 167
2021
Q4
$6.79M Buy
26,740
+20,163
+307% +$5.9M 0.13% 119
2021
Q3
$2.53M Sell
6,577
-436
-6% -$161K 0.1% 95
2021
Q2
$1.65M Sell
7,013
-891
-11% -$159K 0.06% 178
2021
Q1
$1.03M Buy
7,904
+816
+12% +$118K 0.03% 303
2020
Q4
$740K Buy
7,088
+1,180
+20% +$119K 0.02% 349
2020
Q3
$418K Buy
5,908
+1,757
+42% +$123K 0.01% 477
2020
Q2
$267K Buy
+4,151
New +$227K 0.01% 604

Other funds holding MRNA